[{"PropertyPlantAndEquipmentNet_0_Q1_USD":22816000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":45407000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":138627729.0,"DueFromRelatedPartiesCurrent_0_Q1_USD":462000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-8003000.0,"RestrictedCashCurrent_0_Q1_USD":139000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q1_USD":1365000.0,"InterestPaidNet_1_Q1_USD":8913000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-57000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-282052000.0,"FinanceLeaseInterestPaymentOnLiability_1_Q1_USD":36000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":124000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":3282000.0,"MinorityInterestDecreaseFromRedemptions_1_Q1_USD":-91997000.0,"AssetsCurrent_0_Q1_USD":945114000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-5096000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":1494000.0,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":432000.0,"TreasuryStockShares_0_Q1_shares":3174674.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":39386919.0,"FinanceLeaseInterestExpense_1_Q1_USD":28000.0,"TreasuryStockValue_0_Q1_USD":125000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":3488000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":302000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":202000.0,"CommonStockSharesIssued_0_Q1_shares":152289274.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":863267000.0,"Assets_0_Q1_USD":1093308000.0,"LongTermDebtCurrent_0_Q1_USD":3646000.0,"ShareBasedCompensation_1_Q1_USD":33577000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-8003000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"IncreaseDecreaseInDueFromRelatedParties_1_Q1_USD":462000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":3536000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":122559000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":20759000.0,"MinorityInterest_0_Q1_USD":5929000.0,"ProceedsFromStockPlans_1_Q1_USD":1652000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":5766000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":152000.0,"TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests_0_Q1_USD":1271000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":50000000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-12981000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":547912000.0,"MarketableSecuritiesCurrent_0_Q1_USD":447942000.0,"MinorityInterestPeriodIncreaseDecrease_1_Q1_USD":-517000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q1_USD":1996000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":420000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-163079000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-163328000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":1792000.0,"OtherAssetsNoncurrent_0_Q1_USD":30179000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":471176000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":13862000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":767117000.0,"Liabilities_0_Q1_USD":1481402000.0,"FinanceLeaseLiability_0_Q1_USD":1694000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":-249000.0,"OperatingLeaseLiability_0_Q1_USD":17669000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":99200000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":12997000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"RestrictedCashNoncurrent_0_Q1_USD":2459000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":379291000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":67000.0,"FinanceLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0662,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":1021000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":19841000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-150765000.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":82202000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":4344000.0,"LiabilitiesCurrent_0_Q1_USD":94729000.0,"AccountsPayableCurrent_0_Q1_USD":10340000.0,"PaymentsOfDebtIssuanceCosts_1_Q1_USD":16064000.0,"NonoperatingIncomeExpense_1_Q1_USD":-3578000.0,"CommonStockSharesOutstanding_0_Q1_shares":149114600.0,"InterestExpense_1_Q1_USD":9738000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":7464000.0,"LongTermDebtNoncurrent_0_Q1_USD":90762000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":18254000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":445000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0627,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":6113000.0,"FinanceLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":459000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":473774000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":-389365000.0,"OperatingLeasePayments_1_Q1_USD":1470000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":1787000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":25534000.0,"ProceedsFromConvertibleDebt_1_Q1_USD":747500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":115095000.0,"LeaseCost_1_Q1_USD":2173000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":3090000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":3487000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-1448000.0,"OperatingLeaseImpairmentLoss_1_Q1_USD":2600000.0,"CommonStockSharesAuthorized_0_Q1_shares":500000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":462000.0,"OperatingIncomeLoss_1_Q1_USD":-167504000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":50000000.0,"InvestmentIncomeInterest_1_Q1_USD":394000.0,"PreferredStockValue_0_Q1_USD":null,"OperatingLeaseCost_1_Q1_USD":1365000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1093308000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":20741000.0,"PreferredStockSharesAuthorized_0_Q1_shares":25000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":34896000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3807000.0,"OperatingExpenses_1_Q1_USD":167966000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":-3540000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":133000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-1.18,"ProfitLoss_1_Q1_USD":-171082000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":11612000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":200000.0,"StockholdersEquity_0_Q1_USD":-395294000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":1961000.0,"AccretionExpense_1_Q1_USD":1249000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":863324000.0,"VariableLeaseCost_1_Q1_USD":751000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1037506000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":4518000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-171331000.0,"Ticker":"BBIO","CIK":"1743881","name":"BRIDGEBIO PHARMA, INC.","OfficialName":"BridgeBio Pharma Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1594164456.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]